Meanwhile, the previously reviewed results suggest that hypothalamic orexin is an essential factor for preventing NASH and associated HCC under obesity; a novel therapy with orexin supplementation might arise from this review. Here, HCRT is linked to obesity due to melanocortin 4 receptor deficiency.